279 related articles for article (PubMed ID: 22590599)
1. Muramyl dipeptide induces NOD2-dependent Ly6C(high) monocyte recruitment to the lungs and protects against influenza virus infection.
Coulombe F; Fiola S; Akira S; Cormier Y; Gosselin J
PLoS One; 2012; 7(5):e36734. PubMed ID: 22590599
[TBL] [Abstract][Full Text] [Related]
2. Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.
Egarnes B; Gosselin J
Front Immunol; 2018; 9():132. PubMed ID: 29445379
[TBL] [Abstract][Full Text] [Related]
3. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
Hedl M; Abraham C
J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
[TBL] [Abstract][Full Text] [Related]
5. Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.
Coulombe F; Divangahi M; Veyrier F; de Léséleuc L; Gleason JL; Yang Y; Kelliher MA; Pandey AK; Sassetti CM; Reed MB; Behr MA
J Exp Med; 2009 Aug; 206(8):1709-16. PubMed ID: 19581406
[TBL] [Abstract][Full Text] [Related]
6. Selective Immunomodulatory and Neuroprotective Effects of a NOD2 Receptor Agonist on Mouse Models of Multiple Sclerosis.
Fani Maleki A; Cisbani G; Laflamme N; Prefontaine P; Plante MM; Baillargeon J; Rangachari M; Gosselin J; Rivest S
Neurotherapeutics; 2021 Apr; 18(2):889-904. PubMed ID: 33479802
[TBL] [Abstract][Full Text] [Related]
7. Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway.
Kapoor A; Fan YH; Arav-Boger R
Sci Rep; 2016 Feb; 6():20295. PubMed ID: 26830977
[TBL] [Abstract][Full Text] [Related]
8. Triggering of NOD2 Receptor Converts Inflammatory Ly6C
Lessard AJ; LeBel M; Egarnes B; Préfontaine P; Thériault P; Droit A; Brunet A; Rivest S; Gosselin J
Cell Rep; 2017 Aug; 20(8):1830-1843. PubMed ID: 28834747
[TBL] [Abstract][Full Text] [Related]
9. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
10. Nod2 is required for the early innate immune clearance of Acinetobacter baumannii from the lungs.
Kale SD; Dikshit N; Kumar P; Balamuralidhar V; Khameneh HJ; Bin Abdul Malik N; Koh TH; Tan GGY; Tan TT; Mortellaro A; Sukumaran B
Sci Rep; 2017 Dec; 7(1):17429. PubMed ID: 29234083
[TBL] [Abstract][Full Text] [Related]
11. NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.
Yang Z; Fuss IJ; Watanabe T; Asano N; Davey MP; Rosenbaum JT; Strober W; Kitani A
Gastroenterology; 2007 Nov; 133(5):1510-21. PubMed ID: 17915219
[TBL] [Abstract][Full Text] [Related]
12. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation.
Marina-García N; Franchi L; Kim YG; Hu Y; Smith DE; Boons GJ; Núñez G
J Immunol; 2009 Apr; 182(7):4321-7. PubMed ID: 19299732
[TBL] [Abstract][Full Text] [Related]
13. T cell-derived soluble glycoprotein GPIbα mediates PGE
Liu F; Endo Y; Romantseva T; Wu WW; Akue A; Shen RF; Golding H; Zaitseva M
Sci Signal; 2019 Oct; 12(602):. PubMed ID: 31594856
[TBL] [Abstract][Full Text] [Related]
14. NOD2/CARD15 genotype influences MDP-induced cytokine release and basal IL-12p40 levels in primary isolated peripheral blood monocytes.
Beynon V; Cotofana S; Brand S; Lohse P; Mair A; Wagner S; Mussack T; Ochsenkühn T; Folwaczny M; Folwaczny C; Glas J; Török HP
Inflamm Bowel Dis; 2008 Aug; 14(8):1033-40. PubMed ID: 18383179
[TBL] [Abstract][Full Text] [Related]
15. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
[TBL] [Abstract][Full Text] [Related]
16. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
17. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
[TBL] [Abstract][Full Text] [Related]
18. Membrane targeting enhances muramyl dipeptide binding to NOD2 and Arf6-GTPase in mammalian cells.
Hespen CW; Zhao X; Hang HC
Chem Commun (Camb); 2022 Jun; 58(46):6598-6601. PubMed ID: 35584401
[TBL] [Abstract][Full Text] [Related]
19. Freund's adjuvant, NOD2 and mycobacteria.
Behr MA; Divangahi M
Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
[TBL] [Abstract][Full Text] [Related]
20. NOD2 dependent neutrophil recruitment is required for early protective immune responses against infectious Litomosoides sigmodontis L3 larvae.
Ajendra J; Specht S; Ziewer S; Schiefer A; Pfarr K; Parčina M; Kufer TA; Hoerauf A; Hübner MP
Sci Rep; 2016 Dec; 6():39648. PubMed ID: 28004792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
